Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study-Reference-Cited by-同舟云学术

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

Published:2011-10-07 Issue:10 Volume:6 Page:e26091
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Caronia Daniela,Patiño-Garcia Ana,Peréz-Martínez Antonio,Pita Guillermo,Moreno Leticia Tais,Zalacain-Díez Marta,Molina Blanca,Colmenero Isabel,Sierrasesúmaga Luis,Benítez Javier,Gonzalez-Neira Anna

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Chemotherapy resistance in osteosarcoma: current challenges and future directions.;AJ Chou;Expert Rev Anticancer Ther,2006

2. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry.;G Redlich;J Proteome Res,2008

3. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.;JD Hayes;Crit Rev Biochem Mol Biol,1995

4. Pharmacogenetics of membrane transporters: a review of current approaches.;TM Sissung;Methods Mol Biol,2008

5. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.;J Kindla;Expert Opin Drug Metab Toxicol,2009

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility;Future Pharmacology;2024-09-05

2. Advances in drug resistance of osteosarcoma caused by pregnane X receptor;Drug Metabolism Reviews;2024-06-13

3. Revisiting the Effects of MDR1 Variants Using Computational Approaches;Lecture Notes in Computer Science;2024

4. Revisiting the effects of MDR1 Variants using computational approaches;2023-09-03

5. Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review;BMC Cancer;2022-12-19